Cargando…
Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not"
BACKGROUND: Imatinib is a tyrosine-kinase inhibitor; for which there is limited information regarding its effects on AIDS Kaposi's sarcoma and none in patients with transplant-associated Kaposi's sarcoma. Sirolimus, an immunosuppressive drug used for kidney transplant, exhibits antiangioge...
Autores principales: | Volkow, Patricia, Zinser, Juan W, Correa-Rotter, Ricardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852096/ https://www.ncbi.nlm.nih.gov/pubmed/17386117 http://dx.doi.org/10.1186/1471-2369-8-6 |
Ejemplares similares
-
What They Did
Publicado: (1872) -
Kaposi's Sarcoma after Kidney Transplantation: a 21-Years Experience
por: Raeisi, Dariyush, et al.
Publicado: (2013) -
Transplant-associated Kaposi’s sarcoma in a kidney allograft: a case report
por: Lee, Jae Jun, et al.
Publicado: (2023) -
Post-renal transplant Kaposi's sarcoma of skin
por: Gera, D. N., et al.
Publicado: (2013) -
Molecular Mechanisms of Kaposi Sarcoma Development
por: Karabajakian, Andy, et al.
Publicado: (2022)